16-Jan-2026
Catalyst Watch: Intel earnings, drama in Davos, and the fight for Warner Bros.
Seeking Alpha News (Fri, 16-Jan 3:00 PM ET)
TipRanks (Fri, 16-Jan 8:51 AM ET)
Dividend Roundup: Goldman Sachs, Procter & Gamble, Costco, Caterpillar, and more
Seeking Alpha News (Fri, 16-Jan 8:31 AM ET)
Benzinga (Fri, 16-Jan 6:41 AM ET)
Trump unveils 'Great Healthcare Plan' to lower drug prices, premiums
Seeking Alpha News (Thu, 15-Jan 11:38 AM ET)
Pfizer Advances Prazosin Manufacturing Shift With New Bioequivalence Study
TipRanks (Thu, 15-Jan 11:34 AM ET)
Pfizer’s TOFAst Real-World Study in Ulcerative Colitis: What Investors Should Watch
TipRanks (Thu, 15-Jan 11:31 AM ET)
Trump admin rolls back $2B in mental health, addiction grant cuts—report
Seeking Alpha News (Thu, 15-Jan 6:49 AM ET)
Pfizer Advances CGRP Migraine Asset With New Bioequivalence Study
TipRanks (Wed, 14-Jan 11:31 AM ET)
Pfizer Completes Key China Phase 3 Trial for Migraine Drug Rimegepant
TipRanks (Wed, 14-Jan 11:31 AM ET)
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Pfizer trades on the NYSE stock market under the symbol PFE.
As of January 16, 2026, PFE stock price declined to $25.65 with 46,538,179 million shares trading.
PFE has a beta of 0.66, meaning it tends to be less sensitive to market movements. PFE has a correlation of 0.16 to the broad based SPY ETF.
PFE has a market cap of $145.83 billion. This is considered a Large Cap stock.
Last quarter Pfizer reported $17 billion in Revenue and $.87 earnings per share. This beat revenue expectation by $102 million and exceeded earnings estimates by $.22.
In the last 3 years, PFE traded as high as $46.74 and as low as $20.92.
The top ETF exchange traded funds that PFE belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
PFE has underperformed the market in the last year with a return of +3.3%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PFE shares. However, PFE has outperformed the market in the last 3 month and 2 week periods, returning +7.6% and +1.9%, while SPY returned +5.0% and +1.2%, respectively. This indicates PFE has been having a stronger performance recently.
PFE support price is $25.60 and resistance is $26.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PFE shares will trade within this expected range on the day.